现在位置 >首页 > 时讯速递
[JAMA发表论文]:近期使用维生素K拮抗剂与急性缺血性卒中血管内溶栓后脑出血已关闭评论
Original Investigation  June 20, 2023 Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke Brian Mac Grory, DaJuanicia N. Holmes, Roland A. Matsouaka, et al JAMA. 2023;329(23):2038-2049. doi:10.1001/jama.2023.8073 Key Points Question  In patients with acute ischemic stroke due to large vessel occlusion selected to receive endovascular thrombectomy (EVT), does recent...
阅读全文
[BMJ发表论文]:肾移植患者不包括种族的肾小球滤过率估测公式已关闭评论
Research Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study Marc Raynaud, Solaf Al-Awadhi, Ivana Juric, et al BMJ 2023; 381 doi: https://doi.org/10.1136/bmj-2022-073654 (Published 31 May 2023)Cite this as: BMJ 2023;381:e073654 Abstract Objective To compare the performance of a newly developed race-free kidney recipient specific glomerular filtration rate (GFR) equation with the thre...
阅读全文
[NEJM发表论文]:替罗非班治疗无大血管或中型血管闭塞的卒中已关闭评论
ORIGINAL ARTICLE Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion Wenjie Zi, Jiaxing Song, Weilin Kong, et al N Engl J Med 2023; 388:2025-2036DOI: 10.1056/NEJMoa2214299 Abstract BACKGROUND The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not been extensively studied. 背景 糖蛋白Ⅱb/Ⅲa受体...
阅读全文
[BMJ发表论文]:同行审稿人对审稿邀请的反应已关闭评论
Research Analysis of peer reviewers’ response to invitations by gender and geographical region: cohort study of manuscripts reviewed at 21 biomedical journals before and during covid-19 pandemic Khaoula Ben Messaoud, Sara Schroter, Mark Richards, et al BMJ 2023; 381 doi: https://doi.org/10.1136/bmj-2023-075719 (Published 13 June 2023)Cite this as: BMJ 2023;381:e075719 Abstract Objectives To describe gender and geographical inequalities in invitations t...
阅读全文
[JAMA发表论文]:使用Ziritaxestat,一种自分泌运动因子抑制剂,与特发性肺间质纤维化的肺功能已关闭评论
Original Investigation  May 9, 2023 Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials Toby M. Maher, Paul Ford, Kevin K. Brown, et al JAMA. 2023;329(18):1567-1578. doi:10.1001/jama.2023.5355 Key Points Question  Does the autotaxin inhibitor ziritaxestat improve outcomes, compared with placebo, in patients with idiopathic pulmonary fibrosis...
阅读全文
[NEJM Evid发表论文]:小剂量氢化可的松治疗成年感染性休克患者的患者水平meta分析已关闭评论
ORIGINAL ARTICLE Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock Romain Pirracchio, Djillali Annane, Andre K. Waschka, et al NEJM Evid 2023;2(6) DOI: 10.1056/EVIDoa2300034 Abstract BACKGROUND Trials and study-level meta-analyses have failed to resolve the role of corticosteroids in the management of patients with septic shock. Patient-level meta-analyses may provide more precise estimates of treatment effects, partic...
阅读全文
[Lancet Infect Dis发表论文]:奈玛特韦-利托那韦预防新冠病毒感染患者住院和死亡的作用已关闭评论
ARTICLES|ONLINE FIRST Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system Joseph A Lewnard, John M McLaughlin, Debbie Malden, et al Lancet Infect Dis Open Access Published:March 15, 2023 DOI:https://doi.org/10.1016/S1473-3099(23)00118-4 Summary Background In the USA, oral nirmatrelvir–ritonavir is authorised for use in patients aged 12 years or ol...
阅读全文
[Lancet Microbe发表论文]:人接种新冠病毒后病毒在空气和环境中的传播已关闭评论
ARTICLES|ONLINE FIRST Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study Jie Zhou, Anika Singanayagam, Niluka Goonawardane, et al. Lancet Microbe Published:June 09, 2023 DOI:https://doi.org/10.1016/S2666-5247(23)00101-5 Summary Background Effectively implementing strategies to curb SARS-CoV-2 transmission requires understanding who is contagious and when. Although viral load on up...
阅读全文
[NEJM发表论文]:院前使用氨甲环酸治疗严重创伤已关闭评论
ORIGINAL ARTICLE Prehospital Tranexamic Acid for Severe Trauma The PATCH-Trauma Investigators and the ANZICS Clinical Trials Group N Engl J Med June 14, 2023DOI: 10.1056/NEJMoa2215457 Abstract BACKGROUND Whether prehospital administration of tranexamic acid increases the likelihood of survival with a favorable functional outcome among patients with major trauma and suspected trauma-induced coagulopathy who are being treated in advanced trauma systems is ...
阅读全文
[NEJM发表论文]:低塞米松或手术治疗慢性硬膜下血肿已关闭评论
ORIGINAL ARTICLE Dexamethasone versus Surgery for Chronic Subdural Hematoma Ishita P. Miah, Dana C. Holl, Jurre Blaauw, et al N Engl J Med 2023; 388:2230-2240DOI: 10.1056/NEJMoa2216767 Abstract BACKGROUND The role of glucocorticoids without surgical evacuation in the treatment of chronic subdural hematoma is unclear. METHODS In this multicenter, open-label, controlled, noninferiority trial, we randomly assigned symptomatic patients with chronic sub...
阅读全文
×
腾讯微博